Transplantation in utero of fetal human hematopoietic stem cells into mice results in hematopoietic chimerism

Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
J S PixleyF R Mackintosh

Abstract

Allogeneic and xenogeneic hematolymphoid chimerism has been achieved in large and small animals using varied techniques to circumvent immune mediated graft rejection by the recipient. We show here the establishment of long-term chimerism in normal mice transplanted in utero with human fetal hematopoietic stem cells (HSC). HSCs from fetal (13-20 weeks' gestation) human livers were injected into fetal mouse peritoneal cavities on days 11-13 of gestation. Histologic examination demonstrated human chimerism in 29% of 38 live born mice using fluorescein conjugated antibodies to both the CD45 and CD14 antigens present on human peripheral blood (PB) cells. Further investigation using flow cytometric analysis of cells from 70 mice transplanted in utero revealed 28% of mice greater than 16 weeks of age contained human cells in at least one organ at the following frequencies: 14% PB, 8% bone marrow, 8% spleen and 12% thymus. These data indicate that human fetal HSC can be engrafted into mouse fetuses. Additionally, the identification of circulating human cells 18 months following transplantation supports the engraftment and proliferation of a primitive hematopoietic progenitor.

Citations

Nov 25, 1998·British Journal of Haematology·C W TurnerW H Fleming
Aug 16, 2002·British Journal of Haematology·Isabel BarãoJoão L Ascensão
May 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Fanyi ZengShu-zhen Huang
Mar 1, 1994·The Journal of Clinical Investigation·E D ZanjaniM Tavassoli
Aug 5, 2009·World Journal of Gastroenterology : WJG·Yan SunXi-Gu Chen
Feb 16, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Evan CollettiGraça Almeida-Porada
Aug 12, 2009·Experimental and Molecular Pathology·Xin ChenFanyi Zeng
Mar 29, 2014·British Journal of Haematology·Christine JeanblancGraça Almeida-Porada
Mar 17, 2004·Cancer Control : Journal of the Moffitt Cancer Center·Marcus O Muench, Alicia Bárcena

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.